Insider Trading & Ownership - Revance Therapeutics Inc. (RVNC)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Revance Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-05
Sale
2023-09-07
5:37 pm
Revance Therapeutics Inc.RVNCMoxie Dwight
SVP, GC & Secretary
34,853$17.58$612,62444,066
(Direct)
View
2023-08-03
Sale
2023-08-04
5:07 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
26,279$22.57$593,151951,288
(Indirect
Direct)
View
2023-07-03
Sale
2023-07-05
9:11 pm
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
1,701$25.04$42,59379,896
(Direct)
View
2023-07-03
Sale
2023-07-05
9:11 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
26,279$24.94$655,333977,567
(Indirect
Direct)
View
2023-06-15
Sale
2023-06-20
4:25 pm
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
2,500$28.24$70,60024,817
(Direct)
View
2023-06-09
Sale
2023-06-13
8:09 pm
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
5,000$30.82$154,096147,347
(Direct)
View
2023-06-09
Sale
2023-06-13
8:09 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
31,279$30.72$960,9281,002,846
(Indirect
Direct)
View
2023-06-01
Sale
2023-06-05
6:06 pm
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
3,201$30.64$98,07080,828
(Direct)
View
2023-05-15
Sale
2023-05-16
8:29 pm
Revance Therapeutics Inc.RVNCMoxie Dwight
SVP, GC & Secretary
21,401$34.55$739,33869,165
(Direct)
View
2023-05-15
Sale
2023-05-16
8:29 pm
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
21,401$34.55$739,33884,029
(Direct)
View
2023-05-15
Sale
2023-05-16
8:29 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
70,447$34.55$2,433,7251,034,125
(Indirect
Direct)
View
2023-05-15
Sale
2023-05-16
8:29 pm
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
21,015$34.55$726,003152,347
(Direct)
View
2023-05-01
Sale
2023-05-02
4:01 pm
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
3,201$31.7$101,47263,081
(Direct)
View
2023-04-03
Sale
2023-04-04
4:24 pm
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
3,201$32.15$102,91266,282
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-29
Option Award
2024-03-04
5:34 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
22,110$0179,728
(Direct)
View
2024-02-29
Option Award
2024-03-04
5:33 pm
N/A
N/A
Revance Therapeutics Inc.RVNCMoxie Dwight
CLO & GC
15,143$0149,209
(Direct)
View
2024-02-29
Option Award
2024-03-04
4:44 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
17,447$0205,849
(Direct)
View
2024-02-29
Option Award
2024-03-04
4:33 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
70,750$01,096,381
(Direct)
View

Ownership
2024-02-29
4:36 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJordan Erica
Chief Commercial Officer
0$0237,256
(Direct)
View

Ownership
2024-02-29
4:32 pm
N/A
N/A
Revance Therapeutics Inc.RVNCHollander David
CMO & Global Therapeutics Lead
0$0278,522
(Direct)
View
2024-01-31
Option Award
2024-02-02
4:48 pm
2025-02-15
2028-01-31
Revance Therapeutics Inc.RVNCMoxie Dwight
SVP, GC & Secretary
225,000$0269,066
(Direct)
View
2024-01-31
Option Award
2024-02-02
4:46 pm
2025-02-15
2028-01-31
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
241,668$0333,403
(Direct)
View
2024-01-31
Option Award
2024-02-02
4:45 pm
2025-02-15
2028-01-31
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
1,070,001$01,070,001
(Direct)
View
2023-12-31
Option Award
2024-01-03
4:50 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
264$7.47157,618
(Direct)
View
2023-12-31
Option Award
2024-01-03
4:48 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
434$7.4791,735
(Direct)
View
2023-12-31
Option Award
2024-01-03
4:47 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
264$7.471,025,631
(Direct)
View
2023-12-15
Tax Withholding
2023-12-18
4:32 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
4,712$8.08157,354
(Direct)
View
2023-08-11
Option Award
2023-08-15
4:16 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
22,620$091,301
(Direct)
View
2023-08-11
Tax Withholding
2023-08-15
4:16 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
11,215$18.9191,301
(Direct)
View
2023-08-11
Option Award
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCMoxie Dwight
SVP, GC & Secretary
19,346$078,919
(Direct)
View
2023-08-11
Tax Withholding
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCMoxie Dwight
SVP, GC & Secretary
9,592$18.9178,919
(Direct)
View
2023-08-11
Option Award
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
22,620$0162,066
(Direct)
View
2023-08-11
Tax Withholding
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
8,901$18.91162,066
(Direct)
View
2023-08-11
Option Award
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
122,143$01,025,367
(Direct)
View
2023-08-11
Tax Withholding
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
48,064$18.911,025,367
(Direct)
View
2023-06-30
Option Award
2023-07-05
9:11 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
769$15.6179,896
(Direct)
View
2023-06-30
Option Award
2023-07-05
9:11 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
1,000$15.61148,347
(Direct)
View
2023-06-30
Option Award
2023-07-05
9:11 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
1,000$15.61977,567
(Direct)
View
2023-06-15
Exercise
2023-06-20
4:25 pm
N/A
N/A
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
2,500$18.1224,817
(Direct)
View
2023-06-15
Exercise
2023-06-20
4:25 pm
N/A
2032-05-03
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
2,500$024,817
(Direct)
View
2022-02-02
Option Award
2023-05-16
8:29 pm
N/A
N/A
Revance Therapeutics Inc.RVNCMoxie Dwight
SVP, GC & Secretary
42,349$069,165
(Direct)
View
2022-02-02
Option Award
2023-05-16
8:29 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSchilke Tobin
CFO
42,349$084,029
(Direct)
View
2022-02-02
Option Award
2023-05-16
8:29 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
175,649$01,034,125
(Direct)
View
2022-02-02
Option Award
2023-05-16
8:29 pm
N/A
N/A
Revance Therapeutics Inc.RVNCSjuts Dustin S
President
52,395$0152,347
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:15 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCGangolli Julian S
Director
9,449$036,021
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:15 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCWare Olivia C
Director
9,449$022,590
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:14 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCNolet Chris
Director
9,449$034,521
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:14 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
9,449$022,476
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:14 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCRussell Angus C.
Director
9,449$042,421
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:14 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCCoric Vlad
Director
1,575$06,770
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:13 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCBeraud Jill
Director
9,449$034,521
(Direct)
View
2023-03-15
Tax Withholding
2023-03-17
3:22 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
5,341$30.65928,923
(Direct)
View
Goto 0, 1, 2, 3, 4, Next